ArticleNeurophotonics2024
Explainable fNIRS-based pain decoding under pharmacological conditions via deep transfer learning approach.
Article in Neurophotonics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Significance: Assessment of pain and its clinical diagnosis rely on subjective methods which become even more complicated under analgesic drug administrations. Aim: We aim to propose a deep learning (DL)-based transfer learning (TL) methodology for objective classification of functional near-infrared spectroscopy (fNIRS)-derived cortical oxygenated hemoglobin responses to painful and non-painful stimuli presented under different timings post-analgesic and placebo drug administration. Approach: A publicly available fNIRS dataset obtained during painful/non-painful stimuli was used. Separate fNIRS scans were taken under the same protocol before drug (morphine and placebo) administration and at three different timings (30, 60, and 90 min) post-administration. Data from pre-drug fNIRS scans were utilized for constructing a base DL model. Knowledge generated from the pre-drug model was transferred to six distinct post-drug conditions by following a TL approach. The DeepSHAP method was utilized to unveil the contribution weights of nine regions of interest for each of the pre-drug and post-drug decoding models. Results: Accuracy, sensitivity, specificity, and area under curve (AUC) metrics of the pre-drug model were above 90%, whereas each of the post-drug models demonstrated a performance above 90% for the same metrics. Post-placebo models had higher decoding accuracy than post-morphine models. Knowledge obtained from a pre-drug base model could be successfully utilized to build pain decoding models for six distinct brain states that were scanned at three different timings after either analgesic or placebo drug administration. The contribution of different cortical regions to classification performance varied across the post-drug models. Conclusions: The proposed DL-based TL methodology may remove the necessity to build DL models for data collected at clinical or daily life conditions for which obtaining training data is not practical or building a new decoding model will have a computational cost. Unveiling the explanation power of different cortical regions may aid the design of more computationally efficient fNIRS-based brain-computer interface (BCI) system designs that target other application areas.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.